The Gate Keeper Speaks: The FDA at the VentureWire Health Care Innovations Conference
Patients desire improved treatments, voters call for safety, biomed startups want drug approval to continue in business and big pharma is after big profits. The Food and Drug Administration must grapple with these issues, which are only getting more complex. Dr. Steve Galson, director of the FDA’s Center for Drug Evaluation and Research, took the stage at the Dow Jones VentureWire Health Care Innovations 2006 in Redwood City, California, on September 12th, 2006. In this keynote interview Galson tells interviewer Brian Gormley â€” associate editor of the Dow Jones publication Venture Capital Analyst â€”what is on the mind of the FDA lately.